XH-S002
/ Fosun Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 12, 2024
A Phase I Study of XH-S002 in Healthy Volunteers
(clinicaltrials.gov)
- P1 | N=86 | Recruiting | Sponsor: S-Infinity Pharmaceuticals Co., Ltd
New P1 trial
1 to 1
Of
1
Go to page
1